latest update:
[TrialBase DB]

trial summary · NCT07169799

Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)

Evaluating the Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)

Trial record from the TrialBase DB dataset, status RECRUITING, condition Gastric Antral Vascular Ectasia, sponsored by Mayo Clinic. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07169799phase —enrollment 50start 2026-12-22

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The purpose of this study is to evaluate the impact of cryotherapy spray treatment for eradication of gastric antral vascular ectasia by measuring the change in hemoglobin levels and transfusion requirements in the first 6 months of cryotherapy treatment compared to the previous 6 months

Source record: https://clinicaltrials.gov/study/NCT07169799

Facts

registry idNCT07169799
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionGastric Antral Vascular Ectasia
sponsorMayo Clinic
sponsor classOTHER
enrollment50
start date2026-12-22
primary completion2028-09-30
completion2028-12-31
results postednot reported

Conditions

  • Gastric Antral Vascular Ectasia

Interventions

  • trūFreeze® Spray Cryotherapy System (STERIS Endoscopy)

Countries

  • United States

Intervention types: OTHER

Work with this record